Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG384585 Activators

Scgb1b3, a member of the secretoglobin family, plays a pivotal role in cellular processes by virtue of its predicted steroid binding activity and extracellular localization. This multifaceted protein, encoded by the Scgb1b3 gene, is integral to the modulation of steroid responses within the cellular environment. Its predicted activity in the extracellular region implies interactions with external factors, potentially participating in intercellular signaling or communication. Understanding the functional significance of Scgb1b3 is paramount for unraveling its role in cellular homeostasis and response to various stimuli. The activation mechanisms of Scgb1b3 involve intricate regulatory networks and pathways that modulate its expression and function. One of the primary routes involves the up-regulation of Scgb1b3 through the stimulation of adenylate cyclase, leading to increased levels of cyclic AMP (cAMP). Elevated cAMP levels, in turn, activate protein kinase A (PKA), initiating a cascade that positively influences the expression of Scgb1b3. Epigenetic regulation also plays a crucial role, with histone deacetylase (HDAC) inhibitors inducing histone hyperacetylation and favorably impacting Scgb1b3 transcription. Sirtuins, activated by certain compounds, contribute to Scgb1b3 activation through deacetylation processes, underscoring the involvement of post-translational modifications in its regulation.

Disruption of signaling pathways such as TGF-β, PI3K/AKT, and MAPK/ERK influences Scgb1b3 indirectly. Inhibitors targeting these pathways prevent repression or modulation of Scgb1b3, leading to enhanced gene expression and protein activation. The intricate interplay between these pathways reflects the sophisticated regulatory network governing Scgb1b3, allowing for a nuanced response to diverse cellular cues. Overall, the multifaceted nature of Scgb1b3 activation suggests its involvement in a wide array of cellular processes, with its functional significance extending beyond steroid binding to encompass complex interactions within cellular signaling networks. Deciphering these activation mechanisms provides valuable insights into the regulatory landscape of Scgb1b3 and its potential implications in cellular physiology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol, a polyphenol, modulates SIRT1 activity and promotes Scgb1b3 expression. SIRT1 deacetylates specific targets, indirectly enhancing the activation of the Scgb1b3 gene.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A, an HDAC inhibitor, induces histone hyperacetylation, positively affecting Scgb1b3 transcription. This epigenetic modulation leads to increased gene expression and protein activation.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

Nicotinamide, a form of vitamin B3, activates sirtuins, influencing Scgb1b3 through deacetylation. Sirtuin-mediated regulation enhances the activity of Scgb1b3 in response to cellular cues.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542, a TGF-β receptor inhibitor, disrupts TGF-β signaling pathways, indirectly preventing TGF-β-mediated repression of Scgb1b3, resulting in increased gene expression and protein activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, a PI3K inhibitor, attenuates the PI3K/AKT pathway, indirectly influencing Scgb1b3 activation. Disruption of this pathway leads to altered downstream signaling, positively affecting Scgb1b3.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1, a BET bromodomain inhibitor, modulates epigenetic regulation by targeting BRD4. This intervention indirectly promotes Scgb1b3 expression, as BRD4 inhibition alters chromatin structure favorably.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126, a MEK inhibitor, disrupts the MAPK/ERK pathway, indirectly affecting Scgb1b3 activation. Altered MAPK signaling results in modified transcription factors, positively influencing Scgb1b3.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, hinders PI3K activity, indirectly influencing Scgb1b3. Impaired PI3K signaling leads to downstream effects that positively impact the activation of Scgb1b3.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate, an HDAC inhibitor, induces histone hyperacetylation, positively affecting Scgb1b3 transcription. This epigenetic modulation leads to increased gene expression and protein activation.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$184.00
$741.00
$1076.00
$3417.00
$5304.00
23
(2)

A-769662, an AMPK activator, stimulates AMPK activity, leading to increased Scgb1b3 expression. Activated AMPK positively influences the cellular environment, favoring the up-regulation of Scgb1b3.